Angela Dittmer

Ernst Grube Str. 40
Halle, NI 06120, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

A CAF-Fueled TIMP-1/CD63/ITGB1/STAT3 Feedback Loop Promotes Migration and Growth of Breast Cancer Cells.

A CAF-Fueled TIMP-1/CD63/ITGB1/STAT3 Feedback Loop Promotes Migration and Growth of Breast Cancer Cells.

Journal: Cancers
Published: August 26, 2022

BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study.

BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study.

Journal: Virchows Archiv : an international journal of pathology
Published: June 07, 2021

Carcinoma-Associated Fibroblasts Promote Growth of Sox2-Expressing Breast Cancer Cells.

Carcinoma-Associated Fibroblasts Promote Growth of Sox2-Expressing Breast Cancer Cells.

Journal: Cancers
Published: October 26, 2020

Protein‑ and growth‑modulatory effects of carcinoma‑associated fibroblasts on breast cancer cells: Role of interleukin‑6.

Protein‑ and growth‑modulatory effects of carcinoma‑associated fibroblasts on breast cancer cells: Role of interleukin‑6.

Journal: International journal of oncology
Published: July 30, 2019

Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1.

Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1.

Journal: Oncotarget
Published: March 15, 2018

Expression of transmembrane protein 26 (TMEM26) in breast cancer and its association with drug response.

Expression of transmembrane protein 26 (TMEM26) in breast cancer and its association with drug response.

Journal: Oncotarget
Published: December 18, 2015

Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis.

Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis.

Journal: Oncotarget
Published: May 12, 2015

Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.

Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.

Journal: PloS one
Published: September 14, 2012

Akt and p53 are potential mediators of reduced mammary tumor growth by cloroquine and the mTOR inhibitor RAD001.

Akt and p53 are potential mediators of reduced mammary tumor growth by cloroquine and the mTOR inhibitor RAD001.

Journal: Biochemical pharmacology
Published: October 13, 2011
Showing 1-9 of 9

Last Updated: 09/26/2026